Abbott Launches FreeStyle® Libre System in India

MUMBAI, November 2, 2020 — Abbott announced today that the FreeStyle® Libre system is now available for adults and children (above the age of four) living with diabetes in India and women with gestational diabetes (diabetes during pregnancy), offering them the choice to check glucose levels anytime and anywhere, ultimately improving glucose control.

The FreeStyle Libre sensor measures glucose every minute in interstitial fluid through a small (5.5mm long) filament that is inserted just under the skin and held in place with a small adhesive pad. A quick scan of the sensor with a reader provides a real-time glucose reading on demand and a complete picture of a person's glucose levels, without the need of painful,

FreeStyle Libre is designed for users to be able to check their glucose readings much more simply and frequently, and data show that higher scanning frequency of the technology has been shown to significantly improve time in optimal glucose range.

“Abbott’s revolutionary technology has changed the way millions of people manage diabetes globally and we are excited to bring this life changing technology to India,” said Kalyan Sattaru, general manager of the diabetes care business at Abbott. “People with diabetes are at the centre of Abbott’s innovation. We are happy to launch FreeStyle Libre in India that gives millions of Indians access to to high-quality, accurate and pain-free diabetes technology for continuous glucose monitoring. This helps people make more informed health decisions allowing them to live fuller lives.”